A detailed history of Russell Investments Group, Ltd. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 21 shares of PRCT stock, worth $1,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Previous 12 75.0%
Holding current value
$1,859
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.31 - $84.99 $506 - $764
9 Added 75.0%
21 $1,000
Q2 2024

Aug 08, 2024

BUY
$45.73 - $69.19 $548 - $830
12 New
12 $0
Q4 2022

Feb 08, 2023

BUY
$38.78 - $46.78 $5.19 Million - $6.26 Million
133,852 Added 7782.09%
135,572 $5.63 Million
Q3 2022

Nov 04, 2022

BUY
$30.9 - $50.65 $53,148 - $87,118
1,720 New
1,720 $71,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.95B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.